Forbes -
4 Oct 2021 16:00

Last month, we discussed that FibroGen (NASDAQ: FGEN) stock price could rebound over a one-month period after falling 6% in a week, based on the Trefis Machine Learning Engine. However, FGEN stock has seen a decline of over 12% since then, and it is down 5% in the last five trading days...
Share this Article